American Association of Oral and Maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws—2022 update
SL Ruggiero, TB Dodson, T Aghaloo… - Journal of oral and …, 2022 - Elsevier
Strategies for management of patients with, or at risk for, medication-related osteonecrosis of
the jaws (MRONJ)–formerly referred to as bisphosphonate-related osteonecrosis of the jaws …
the jaws (MRONJ)–formerly referred to as bisphosphonate-related osteonecrosis of the jaws …
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus
AA Khan, A Morrison, DA Hanley… - Journal of Bone and …, 2015 - academic.oup.com
This work provides a systematic review of the literature from January 2003 to April 2014
pertaining to the incidence, pathophysiology, diagnosis, and treatment of osteonecrosis of …
pertaining to the incidence, pathophysiology, diagnosis, and treatment of osteonecrosis of …
Medication-related osteonecrosis of the jaw: MASCC/ISOO/ASCO clinical practice guideline
N Yarom, CL Shapiro, DE Peterson… - Journal of Clinical …, 2019 - pure.au.dk
PURPOSE To provide guidance regarding best practices in the prevention and
management of medicationrelated osteonecrosis of the jaw (MRONJ) in patients with …
management of medicationrelated osteonecrosis of the jaw (MRONJ) in patients with …
American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update
SL Ruggiero, TB Dodson, J Fantasia… - Journal of oral and …, 2014 - Elsevier
Strategies for management of patients with, or at risk for, medication-related osteonecrosis of
the jaw (MRONJ) were set forth in the American Association of Oral and Maxillofacial …
the jaw (MRONJ) were set forth in the American Association of Oral and Maxillofacial …
[HTML][HTML] Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases
S Otto, C Pautke, T Van den Wyngaert, D Niepel… - Cancer treatment …, 2018 - Elsevier
Medication-related osteonecrosis of the jaw (MRONJ) is primarily an adverse side effect of
denosumab or bisphosphonates (particularly when used at high doses to prevent skeletal …
denosumab or bisphosphonates (particularly when used at high doses to prevent skeletal …
Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review
R Fliefel, M Tröltzsch, J Kühnisch, M Ehrenfeld… - International journal of …, 2015 - Elsevier
The aim of this systematic review was to answer the question: What are the treatments
available for bisphosphonate-related osteonecrosis of the jaws (BRONJ) and their …
available for bisphosphonate-related osteonecrosis of the jaws (BRONJ) and their …
American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws—2009 update
SL Ruggiero, TB Dodson, LA Assael… - Journal of Oral and …, 2009 - joms.org
American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related
Osteonecrosis of the Jaws—2009 Update - Journal of Oral and Maxillofacial Surgery Skip to …
Osteonecrosis of the Jaws—2009 Update - Journal of Oral and Maxillofacial Surgery Skip to …
Case-based review of osteonecrosis of the jaw (ONJ) and application of the international recommendations for management from the international task force on ONJ
Osteonecrosis of the jaw (ONJ) has been associated with antiresorptive therapy in both
oncology and osteoporosis patients. This debilitating condition is very rare and advances in …
oncology and osteoporosis patients. This debilitating condition is very rare and advances in …
Osteonecrosis of the jaw and antiresorptive agents in benign and malignant diseases: a critical review organized by the ECTS
AD Anastasilakis, J Pepe, N Napoli… - The Journal of …, 2022 - academic.oup.com
Context Antiresorptive therapy significantly reduces fracture risk in patients with benign bone
disease and skeletal-related events (SREs) in patients with bone metastases (BM) …
disease and skeletal-related events (SREs) in patients with bone metastases (BM) …
Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure
JC Lo, FS O'Ryan, NP Gordon, J Yang, RL Hui… - Journal of Oral and …, 2010 - Elsevier
PURPOSE: Osteonecrosis of the jaw (ONJ) is a serious complication associated with
bisphosphonate therapy, but its epidemiology in the setting of oral bisphosphonate therapy …
bisphosphonate therapy, but its epidemiology in the setting of oral bisphosphonate therapy …